Hypertrophic Cardiomyopathy Is at Increased Risk of Thromboembolic Events: Deficiencies of CHA2DS2-VASC Score and How to Predict
Abstract
Patients with hypertrophic cardiomyopathy (HCM) are at increased risk of potentially catastrophic thromboembolic (TE) events that can occur without any previous clinical symptoms.1Guttmann O.P. Pavlou M. ÓMahony C. et al.Predictors of atrial fibrillation in hypertrophic cardiomyopathy.Heart. 2017; 103: 672-678Crossref PubMed Scopus (54) Google Scholar, 2Veselka J. Zemánek D. Jahnlová D. et al.Risk and causes of death in patients after alcohol...
Paper Details
Title
Hypertrophic Cardiomyopathy Is at Increased Risk of Thromboembolic Events: Deficiencies of CHA2DS2-VASC Score and How to Predict
Published Date
Dec 1, 2019
Volume
35
Issue
12
Pages
1629 - 1630
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History